Belgium· BE-AMP-SAM378533-00
Brinavess 20 mg/ml
A vernakalant product containing vernakalant hydrochloride, registered in Belgium by Advanz Pharma. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Vernakalant is registered in 12 of 19 countries.
Countries holding a registration under ATC C01BG11 (vernakalant), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Vernakalant · ATC C01BG11
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Vernakalant Hydrochloride
- Manufacturer
- Advanz Pharma
- Country
- Belgium (BE)
- ATC code
- C01BG11
- ATC class
- Vernakalant
- Defined daily dose
- 0.2 g, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb7712680
- be_apb2752293
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vernakalant in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBRINAVESSADVANZ PHARMA Limited, Dublin
- FinlandBRINAVESSAdvanz Pharma Limited
- IcelandBrinavessADVANZ PHARMA Limited
- PolandBrinavessCorrevio
- SwedenBRINAVESS 20 mg/ml Koncentrat till infusionsvätska, lösningAdvanz Pharma Limited
- IrelandBRINAVESS 20 mg/ml concentrate for solution for infusionCorrevio
- CanadaBRINAVESSCIPHER PHARMACEUTICALS INC
- SpainBRINAVESS 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSIONAdvanz Pharma Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Brinavess
- Liechtenstein · Brinavess
- Norway · Brinavess
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/836f2b27-61b4-4aaa-8fb5-03338a4ed4eb GET /v1/drugs/836f2b27-61b4-4aaa-8fb5-03338a4ed4eb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Brinavess 20 mg/ml",
"name_fr": "Brinavess 20 mg/ml",
"name_nl": "Brinavess 20 mg/ml",
"amp_code": "SAM378533-00",
"strengths": [
"20.0000",
"20.0000",
"18.1000",
"18.1000"
],
"pack_count": 1,
"substances": [
"Vernakalant Hydrochloride",
"Vernakalant",
"Sodium Chloride",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Vernakalant",
"authorisation_numbers": [
"EU/1/10/645/002"
]
}See everything about vernakalant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.